Richard J Swift
Insider
Erste SEC-Einreichung: 17. November 2010 · Neueste: 17. November 2010
Insider bei
Insider-Transaktionen
0 Käufe (P)
0 Verkäufe (S)
Netto: $0
Preisänderung im Vergleich zum aktuellen Kurs, bereinigt um Aktiensplits und Unternehmensmaßnahmen seit der Einreichung – nicht benchmarkt, nicht annualisiert, nicht größen-gewichtet
| Date | Ticker | Code | Aktien | Kurs | Wert | Besessen danach | Δ Eigenbesitz | A/D | vs jetzt |
|---|---|---|---|---|---|---|---|---|---|
| 3. Juni 2021 | TT | F | 654 | $183,36 | $119.917 | 87.404 Direkt | -0,74% | Veräußert | 156,7% (Preis per 2026-10-05) |
| 27. August 2020 | TT | S | 4.354 | $120,02 | $522.567 | 87.065 Direkt | -4,76% | Veräußert | 292,2% (Preis per 2026-10-05) |
| 6. Juni 2020 | TT | F | 802 | $102,01 | $81.812 | 90.912 Direkt | -0,87% | Veräußert | 361,5% (Preis per 2026-10-05) |
| 4. Juni 2020 | TT | A | 1.701 | · | · | 91.714 Direkt | +1,89% | Erworben | (Preis per 2026-10-05) |
| 20. November 2019 | CVS | A | 1.676 | $74,92 | $125.566 | 7.336 Direkt | +29,61% | Erworben | 16,1% (Preis per 2026-10-05) |
| 7. Juni 2019 | TT | F | 866 | $125,22 | $108.441 | 69.699 Direkt | -1,23% | Veräußert | 384,6% (Preis per 2026-10-05) |
| 6. Juni 2019 | TT | A | 1.301 | · | · | 70.565 Direkt | +1,88% | Erworben | (Preis per 2026-10-05) |
| 16. Mai 2019 | CVS | A | 2.402 | $52,30 | $125.625 | 5.660 Direkt | +73,73% | Erworben | 66,4% (Preis per 2026-10-05) |
| 1. Mai 2019 | PEG | A | 2.297 | $58,78 | $135.018 | 47.278 Direkt | +5,11% | Erworben | 16,8% (Preis per 2026-10-05) |
| 7. November 2018 | CVS | A | 1.452 | $78,77 | $114.374 | 62.371 Direkt | +2,38% | Erworben | 10,5% (Preis per 2026-10-05) |
| 8. Juni 2018 | TT | F | 778 | $90,50 | $70.409 | 67.924 Direkt | -1,13% | Veräußert | 570,5% (Preis per 2026-10-05) |
| 7. Juni 2018 | TT | A | 1.804 | · | · | 68.702 Direkt | +2,70% | Erworben | (Preis per 2026-10-05) |
| 4. Juni 2018 | CVS | A | 1.784 | $64,10 | $114.354 | 60.044 Direkt | +3,06% | Erworben | 35,7% (Preis per 2026-10-05) |
| 3. Mai 2018 | HUBB | A | 1.172 | · | · | 5.313 Direkt | +28,30% | Erworben | (Preis per 2026-10-05) |
| 1. Mai 2018 | PEG | A | 2.604 | $51,86 | $135.043 | 43.509 Direkt | +6,37% | Erworben | 32,4% (Preis per 2026-10-05) |
| 15. November 2017 | HUBB | S | 100 | $120,56 | $12.056 | 6.041 Direkt | -1,63% | Veräußert | 298,7% (Preis per 2026-10-05) |
| 15. November 2017 | HUBB | S | 100 | $120,55 | $12.055 | 5.941 Direkt | -1,66% | Veräußert | 298,7% (Preis per 2026-10-05) |
| 15. November 2017 | HUBB | S | 739 | $120,51 | $89.057 | 5.202 Direkt | -12,44% | Veräußert | 298,8% (Preis per 2026-10-05) |
| 15. November 2017 | HUBB | S | 1.061 | $120,60 | $127.957 | 4.141 Direkt | -20,40% | Veräußert | 298,5% (Preis per 2026-10-05) |
| 8. November 2017 | CVS | A | 1.658 | $68,99 | $114.385 | 57.420 Direkt | +2,97% | Erworben | 26,1% (Preis per 2026-10-05) |
| 16. August 2017 | CVS | S | 2.500 | $79,62 | $199.050 | 3.258 Direkt | -43,42% | Veräußert | 9,3% (Preis per 2026-10-05) |
| 7. August 2017 | TT | S | 2.500 | $88,03 | $220.075 | 65.932 Direkt | -3,65% | Veräußert | 589,3% (Preis per 2026-10-05) |
| 8. Juni 2017 | TT | A | 1.620 | · | · | 68.159 Direkt | +2,43% | Erworben | (Preis per 2026-10-05) |
| 2. Juni 2017 | TT | F | 1.032 | $89,64 | $92.508 | 66.539 Direkt | -1,53% | Veräußert | 576,9% (Preis per 2026-10-05) |
| 10. Mai 2017 | CVS | A | 1.413 | $80,94 | $114.368 | 55.013 Direkt | +2,64% | Erworben | 7,5% (Preis per 2026-10-05) |
| 2. Mai 2017 | HUBB | A | 1.060 | · | · | 6.141 Direkt | +20,86% | Erworben | (Preis per 2026-10-05) |
| 1. Mai 2017 | PEG | A | 3.089 | $43,71 | $135.020 | 39.442 Direkt | +8,50% | Erworben | 57,1% (Preis per 2026-10-05) |
| 2. November 2016 | CVS | A | 625 | $83,95 | $52.469 | 53.044 Direkt | +1,19% | Erworben | 3,6% (Preis per 2026-10-05) |
| 2. November 2016 | CVS | A | 737 | $83,95 | $61.871 | 5.758 Direkt | +14,68% | Erworben | 3,6% (Preis per 2026-10-05) |
| 6. September 2016 | TT | S | 2.100 | $67,99 | $142.779 | 66.648 Direkt | -3,05% | Veräußert | 792,5% (Preis per 2026-10-05) |
| 29. Juli 2016 | HUBB | S | 100 | $107,12 | $10.712 | 5.081 Direkt | -1,93% | Veräußert | 348,7% (Preis per 2026-10-05) |
| 29. Juli 2016 | HUBB | S | 4.203 | $107,13 | $450.267 | 5.181 Direkt | -44,79% | Veräußert | 348,7% (Preis per 2026-10-05) |
| 4. Juni 2016 | TT | F | 996 | $65,90 | $65.636 | 68.440 Direkt | -1,43% | Veräußert | 820,8% (Preis per 2026-10-05) |
| 2. Juni 2016 | TT | A | 2.150 | · | · | 69.436 Direkt | +3,20% | Erworben | (Preis per 2026-10-05) |
| 19. Mai 2016 | CVS | A | 520 | $100,95 | $52.494 | 51.789 Direkt | +1,01% | Erworben | -13,8% (Preis per 2026-10-05) |
| 19. Mai 2016 | CVS | A | 612 | $100,95 | $61.781 | 5.021 Direkt | +13,88% | Erworben | -13,8% (Preis per 2026-10-05) |
| 3. Mai 2016 | HUBB | A | 1.141 | · | · | 9.384 Direkt | +13,84% | Erworben | (Preis per 2026-10-05) |
| 2. Mai 2016 | PEG | A | 2.924 | $46,17 | $135.001 | 20.687 Direkt | +16,46% | Erworben | 48,8% (Preis per 2026-10-05) |
| 23. Dezember 2015 | HUBB | J | 16.708 | · | · | 16.708 Direkt | · | Erworben | (Preis per 2026-10-05) |
| 23. Dezember 2015 | HUBB | J | 7.342 | · | · | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-10-05) |
| 23. Dezember 2015 | HUBB | J | 8.243 | · | · | 8.243 Direkt | -50,00% | Veräußert | (Preis per 2026-10-05) |
| 23. Dezember 2015 | HUBB | J | 8.243 | · | · | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-10-05) |
| 30. November 2015 | TT | S | 2.000 | $58,50 | $117.000 | 66.656 Direkt | -2,91% | Veräußert | 937,3% (Preis per 2026-10-05) |
| 16. November 2015 | HUBB | S | 1.000 | $96,75 | $96.750 | 8.243 Direkt | -10,82% | Veräußert | 396,8% (Preis per 2026-10-05) |
| 5. November 2015 | TT | S | 2.000 | $59,86 | $119.720 | 68.656 Direkt | -2,83% | Veräußert | 913,7% (Preis per 2026-10-05) |
| 5. November 2015 | HUBB | S | 1.000 | $96,73 | $96.730 | 9.243 Direkt | -9,76% | Veräußert | 396,9% (Preis per 2026-10-05) |
| 4. November 2015 | CVS | A | 1.149 | $99,57 | $114.406 | 50.827 Direkt | +2,31% | Erworben | -12,6% (Preis per 2026-10-05) |
| 4. Juni 2015 | TT | A | 2.075 | · | · | 70.055 Direkt | +3,05% | Erworben | (Preis per 2026-10-05) |
| 12. Mai 2015 | TT | S | 1.238 | $67,07 | $83.033 | 67.980 Direkt | -1,79% | Veräußert | 804,7% (Preis per 2026-10-05) |
| 7. Mai 2015 | CVS | A | 1.151 | $99,36 | $114.363 | 49.353 Direkt | +2,39% | Erworben | -12,4% (Preis per 2026-10-05) |
| 5. Mai 2015 | HUBB | A | 1.001 | · | · | 10.243 Direkt | +10,83% | Erworben | (Preis per 2026-10-05) |
| 1. Mai 2015 | PEG | A | 2.860 | $41,96 | $120.006 | 17.763 Direkt | +19,19% | Erworben | 63,7% (Preis per 2026-10-05) |
| 25. Februar 2015 | TT | F | 1.144 | $68,18 | $77.998 | 68.964 Direkt | -1,63% | Veräußert | 790,0% (Preis per 2026-10-05) |
| 14. November 2014 | HUBB | A | 83 | $226,85 | $18.829 | 7.149 Direkt | +1,17% | Erworben | 111,9% (Preis per 2026-10-05) |
| 5. November 2014 | CVS | A | 1.307 | $87,50 | $114.362 | 47.865 Direkt | +2,81% | Erworben | -0,6% (Preis per 2026-10-05) |
| 15. August 2014 | HUBB | A | 77 | $243,06 | $18.716 | 7.037 Direkt | +1,11% | Erworben | 97,7% (Preis per 2026-10-05) |
| 23. Juli 2014 | TT | S | 3.500 | $64,26 | $224.910 | 69.611 Direkt | -4,79% | Veräußert | 844,3% (Preis per 2026-10-05) |
| 15. Mai 2014 | HUBB | A | 82 | $227,30 | $18.639 | 6.931 Direkt | +1,20% | Erworben | 111,5% (Preis per 2026-10-05) |
| 8. Mai 2014 | CVS | A | 1.508 | $75,86 | $114.397 | 46.243 Direkt | +3,37% | Erworben | 14,7% (Preis per 2026-10-05) |
| 6. Mai 2014 | HUBB | A | 939 | · | · | 9.242 Direkt | +11,31% | Erworben | (Preis per 2026-10-05) |
| 1. Mai 2014 | PEG | A | 2.966 | $40,46 | $120.004 | 14.903 Direkt | +24,85% | Erworben | 69,7% (Preis per 2026-10-05) |
| 25. Februar 2014 | TT | A | 2.382 | · | · | 72.620 Direkt | +3,39% | Erworben | (Preis per 2026-10-05) |
| 25. Februar 2014 | TT | A | 2.382 | · | · | 72.620 Direkt | +3,39% | Erworben | (Preis per 2026-10-05) |
| 14. Februar 2014 | HUBB | A | 81 | $230,09 | $18.637 | 6.819 Direkt | +1,20% | Erworben | 108,9% (Preis per 2026-10-05) |
| 15. November 2013 | HUBB | A | 91 | $206,37 | $18.780 | 6.704 Direkt | +1,38% | Erworben | 132,9% (Preis per 2026-10-05) |
| 6. November 2013 | CVS | A | 1.673 | $63,87 | $106.855 | 44.384 Direkt | +3,92% | Erworben | 36,2% (Preis per 2026-10-05) |
| 30. September 2013 | TT | A | 150 | $64,94 | $9.741 | 58.176 Direkt | +0,26% | Erworben | 1069,9% (Preis per 2026-10-05) |
| 15. August 2013 | HUBB | A | 93 | $202,52 | $18.834 | 6.583 Direkt | +1,43% | Erworben | 137,3% (Preis per 2026-10-05) |
| 28. Juni 2013 | TT | A | 175 | $55,52 | $9.716 | 58.026 Direkt | +0,30% | Erworben | 1268,4% (Preis per 2026-10-05) |
| 15. Mai 2013 | HUBB | A | 100 | $187,51 | $18.751 | 6.459 Direkt | +1,57% | Erworben | 156,3% (Preis per 2026-10-05) |
| 9. Mai 2013 | CVS | A | 1.859 | $57,49 | $106.874 | 42.249 Direkt | +4,60% | Erworben | 51,3% (Preis per 2026-10-05) |
| 7. Mai 2013 | HUBB | A | 1.134 | · | · | 8.303 Direkt | +15,82% | Erworben | (Preis per 2026-10-05) |
| 1. Mai 2013 | PEG | A | 3.007 | $36,59 | $110.026 | 11.937 Direkt | +33,67% | Erworben | 87,7% (Preis per 2026-10-05) |
| 28. März 2013 | TT | A | 176 | $55,01 | $9.682 | 57.851 Direkt | +0,31% | Erworben | 1281,1% (Preis per 2026-10-05) |
| 15. März 2013 | HUBB | A | 31 | $183,71 | $5.695 | 6.359 Direkt | +0,49% | Erworben | 161,6% (Preis per 2026-10-05) |
| 15. Februar 2013 | HUBB | A | 104 | $179,43 | $18.661 | 6.328 Direkt | +1,67% | Erworben | 167,9% (Preis per 2026-10-05) |
| 28. Dezember 2012 | TT | A | 157 | $46,88 | $7.360 | 57.675 Direkt | +0,27% | Erworben | 1520,6% (Preis per 2026-10-05) |
| 26. Dezember 2012 | HUBB | A | 35 | $160,12 | $5.604 | 6.224 Direkt | +0,57% | Erworben | 200,2% (Preis per 2026-10-05) |
| 13. Dezember 2012 | HUBB | S | 1.100 | $83,65 | $92.015 | 7.169 Direkt | -13,30% | Veräußert | 474,6% (Preis per 2026-10-05) |
| 15. November 2012 | HUBB | A | 123 | $151,99 | $18.695 | 6.189 Direkt | +2,03% | Erworben | 216,2% (Preis per 2026-10-05) |
| 15. November 2012 | PEG | S | 6.215 | $29,14 | $181.105 | 10.039 Direkt | -38,24% | Veräußert | 135,7% (Preis per 2026-10-05) |
| 15. November 2012 | PEG | S | 5.079 | $29,13 | $147.951 | 16.254 Direkt | -23,81% | Veräußert | 135,8% (Preis per 2026-10-05) |
| 15. November 2012 | PEG | S | 2.414 | $29,13 | $70.320 | 21.333 Direkt | -10,17% | Veräußert | 135,8% (Preis per 2026-10-05) |
| 15. November 2012 | PEG | S | 1.300 | $29,14 | $37.882 | 23.747 Direkt | -5,19% | Veräußert | 135,7% (Preis per 2026-10-05) |
| 15. November 2012 | PEG | S | 600 | $29,14 | $17.484 | 25.047 Direkt | -2,34% | Veräußert | 135,7% (Preis per 2026-10-05) |
| 15. November 2012 | PEG | S | 300 | $29,13 | $8.739 | 25.647 Direkt | -1,16% | Veräußert | 135,8% (Preis per 2026-10-05) |
| 15. November 2012 | PEG | S | 300 | $29,14 | $8.742 | 25.947 Direkt | -1,14% | Veräußert | 135,7% (Preis per 2026-10-05) |
| 8. November 2012 | CVS | A | 2.261 | $46,43 | $104.978 | 40.212 Direkt | +5,96% | Erworben | 87,4% (Preis per 2026-10-05) |
| 11. Oktober 2012 | HUBB | A | 30 | $162,37 | $4.871 | 6.065 Direkt | +0,50% | Erworben | 196,0% (Preis per 2026-10-05) |
| 28. September 2012 | TT | A | 163 | $44,82 | $7.306 | 57.518 Direkt | +0,28% | Erworben | 1595,1% (Preis per 2026-10-05) |
| 15. August 2012 | HUBB | A | 120 | $156,32 | $18.758 | 6.035 Direkt | +2,03% | Erworben | 207,5% (Preis per 2026-10-05) |
| 11. Juli 2012 | HUBB | A | 30 | $158,22 | $4.747 | 5.915 Direkt | +0,51% | Erworben | 203,8% (Preis per 2026-10-05) |
| 29. Juni 2012 | TT | A | 173 | $42,18 | $7.297 | 57.355 Direkt | +0,30% | Erworben | 1701,2% (Preis per 2026-10-05) |
| 15. Mai 2012 | HUBB | A | 128 | $146,10 | $18.701 | 5.884 Direkt | +2,22% | Erworben | 229,0% (Preis per 2026-10-05) |
| 10. Mai 2012 | CVS | A | 2.284 | $45,97 | $104.995 | 37.558 Direkt | +6,48% | Erworben | 89,3% (Preis per 2026-10-05) |
| 8. Mai 2012 | HUBB | A | 1.398 | · | · | 8.269 Direkt | +20,35% | Erworben | (Preis per 2026-10-05) |
| 1. Mai 2012 | PEG | A | 3.496 | $31,47 | $110.019 | 8.930 Direkt | +64,34% | Erworben | 118,2% (Preis per 2026-10-05) |
| 11. April 2012 | HUBB | J | 32 | $147,96 | $4.735 | 5.756 Direkt | +0,56% | Erworben | 224,9% (Preis per 2026-10-05) |
| 30. März 2012 | TT | A | 176 | $41,35 | $7.278 | 57.182 Direkt | +0,31% | Erworben | 1737,3% (Preis per 2026-10-05) |
| 15. Februar 2012 | HUBB | A | 128 | $146,45 | $18.746 | 5.724 Direkt | +2,29% | Erworben | 228,2% (Preis per 2026-10-05) |
Zeige die neuesten 100 von 316 Transaktionen
K = Kauf auf offener Markt · V = Verkauf · A = Zuteilung/Auszeichnung · M = Optionsausübung · G = Geschenk · F = Steuereinbehalt
Insider-Transaktionen sind keine Empfehlung; Verkäufe werden oft aus Liquiditäts- oder steuerlichen Gründen getätigt.
Derivate-Bestände (Formular 4 Tabelle II) Optionen, RSUs und wandelbare Wertpapiere, die in Formular 4 Tabelle II gemeldet werden.
| Date | Ticker | Wertpapier | Basiswert | Ausübungspreis | Verfall | Aktien | A/D |
|---|---|---|---|---|---|---|---|
| 1. Mai 2019 | PEG | Restricted Stock Units | Common Stock | · | · | 2.297 | Erworben |
| 7. November 2018 | CVS | Share Credits | Common Stock | $0,00 | · | 1.452 | Erworben |
| 4. Juni 2018 | CVS | Share Credits | Common Stock | $0,00 | · | 1.784 | Erworben |
| 1. Mai 2018 | PEG | Restricted Stock Units | Common Stock | · | · | 2.604 | Erworben |
| 8. November 2017 | CVS | Share Credits | Common Stock | $0,00 | · | 1.658 | Erworben |
| 10. Mai 2017 | CVS | Share Credits | Common Stock | $0,00 | · | 1.413 | Erworben |
| 1. Mai 2017 | PEG | Restricted Stock Units | Common Stock | · | · | 3.089 | Erworben |
| 2. November 2016 | CVS | Share Credits | Common Stock | $0,00 | · | 625 | Erworben |
| 19. Mai 2016 | CVS | Share Credits | Common Stock | $0,00 | · | 520 | Erworben |
| 2. Mai 2016 | PEG | Phantom Stock | Common Stock | · | · | 2.924 | Erworben |
| 23. Dezember 2015 | HUBB | Directors Deferred Compensation Stock Units | Common Stock | · | · | 16.708 | Erworben |
| 23. Dezember 2015 | HUBB | Directors Deferred Compensation Stock Units | Class A and Class B Common Stock | · | · | 7.342 | Veräußert |
| 4. November 2015 | CVS | Share Credits | Common Stock | $0,00 | · | 1.149 | Erworben |
| 7. Mai 2015 | CVS | Share Credits | Common Stock | $0,00 | · | 1.151 | Erworben |
| 1. Mai 2015 | PEG | Phantom Stock | Common Stock | · | · | 2.860 | Erworben |
| 14. November 2014 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 83 | Erworben |
| 5. November 2014 | CVS | Share Credits | Common Stock | $0,00 | · | 1.307 | Erworben |
| 15. August 2014 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 77 | Erworben |
| 15. Mai 2014 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 82 | Erworben |
| 8. Mai 2014 | CVS | Share Credits | Common Stock | $0,00 | · | 1.508 | Erworben |
| 1. Mai 2014 | PEG | Phantom Stock | Common Stock | · | · | 2.966 | Erworben |
| 14. Februar 2014 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 81 | Erworben |
| 15. November 2013 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 91 | Erworben |
| 6. November 2013 | CVS | Share Credits | Common Stock | $0,00 | · | 1.673 | Erworben |
| 15. August 2013 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 93 | Erworben |
| 15. Mai 2013 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 100 | Erworben |
| 9. Mai 2013 | CVS | Share Credits | Common Stock | $0,00 | · | 1.859 | Erworben |
| 1. Mai 2013 | PEG | Phantom Stock | Common Stock | · | · | 3.007 | Erworben |
| 15. März 2013 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 31 | Erworben |
| 15. Februar 2013 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 104 | Erworben |
| 26. Dezember 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 35 | Erworben |
| 15. November 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 123 | Erworben |
| 8. November 2012 | CVS | Share Credits | Common Stock | $0,00 | · | 2.261 | Erworben |
| 11. Oktober 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 30 | Erworben |
| 15. August 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 120 | Erworben |
| 11. Juli 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 30 | Erworben |
| 15. Mai 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 128 | Erworben |
| 10. Mai 2012 | CVS | Share Credits | Common Stock | $0,00 | · | 2.284 | Erworben |
| 1. Mai 2012 | PEG | Phantom Stock | Common Stock | · | · | 3.496 | Erworben |
| 11. April 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 32 | Erworben |
| 15. Februar 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 128 | Erworben |
| 11. Januar 2012 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 32 | Erworben |
| 20. Dezember 2011 | PEG | Phantom Stock | Common Stock | · | · | 443 | Erworben |
| 15. November 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 153 | Erworben |
| 2. November 2011 | CVS | Share Credits | Common Stock | $0,00 | · | 2.726 | Erworben |
| 11. Oktober 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 40 | Erworben |
| 30. September 2011 | PEG | Phantom Stock | Common Stock | · | · | 408 | Erworben |
| 15. August 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 182 | Erworben |
| 11. Juli 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 31 | Erworben |
| 30. Juni 2011 | PEG | Phantom Stock | Common Stock | · | · | 433 | Erworben |
| 15. Mai 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 142 | Erworben |
| 11. Mai 2011 | CVS | Share Credits | Common Stock | $0,00 | · | 2.600 | Erworben |
| 3. Mai 2011 | TT | Stock Option (Right to Buy) | Ordinary Shares | $21,49 | 28. Mai 2013 | 4.500 | Veräußert |
| 3. Mai 2011 | TT | Stock Option (Right to Buy) | Ordinary Shares | $24,49 | 30. April 2012 | 4.500 | Veräußert |
| 2. Mai 2011 | PEG | Phantom Stock | Common Stock | · | · | 3.108 | Erworben |
| 11. April 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 28 | Erworben |
| 31. März 2011 | PEG | Phantom Stock | Common Stock | · | · | 473 | Erworben |
| 15. Februar 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 136 | Erworben |
| 11. Januar 2011 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 30 | Erworben |
| 31. Dezember 2010 | PEG | Phantom Stock | Common Stock | · | · | 474 | Erworben |
| 21. Dezember 2010 | PEG | Phantom Stock | Common Stock | · | · | 48 | Erworben |
| 20. Dezember 2010 | PEG | Phantom Stock | Common Stock | · | · | 47 | Erworben |
| 16. November 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 143 | Erworben |
| 15. November 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 47 | Erworben |
| 15. November 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 165 | Erworben |
| 4. November 2010 | CVS | Share Credits | Common Stock | $0,00 | · | 4.126 | Erworben |
| 15. Oktober 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 45 | Erworben |
| 14. Oktober 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 45 | Erworben |
| 11. Oktober 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 33 | Erworben |
| 30. September 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 452 | Erworben |
| 21. September 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 46 | Erworben |
| 15. August 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 196 | Erworben |
| 20. Juli 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 136 | Erworben |
| 19. Juli 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 45 | Erworben |
| 12. Juli 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 40 | Erworben |
| 30. Juni 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 473 | Erworben |
| 15. Juni 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 46 | Erworben |
| 14. Juni 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 46 | Erworben |
| 15. Mai 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 183 | Erworben |
| 12. Mai 2010 | CVS | Share Credits | Common Stock | $0,00 | · | 3.579 | Erworben |
| 3. Mai 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 3.052 | Erworben |
| 20. April 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 147 | Erworben |
| 9. April 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 30 | Erworben |
| 31. März 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 511 | Erworben |
| 16. Februar 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 98 | Erworben |
| 15. Februar 2010 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 149 | Erworben |
| 12. Februar 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 168 | Erworben |
| 11. Januar 2010 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 29 | Erworben |
| 31. Dezember 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 446 | Erworben |
| 15. Dezember 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 45 | Erworben |
| 14. Dezember 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 45 | Erworben |
| 17. November 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 190 | Erworben |
| 16. November 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 47 | Erworben |
| 13. November 2009 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 166 | Erworben |
| 4. November 2009 | CVS | Share Credits | Common Stock | $0,00 | · | 3.596 | Erworben |
| 12. Oktober 2009 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 30 | Erworben |
| 30. September 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 476 | Erworben |
| 14. August 2009 | HUBB | Directors Deferred Compensation Stock Units [F1] | Class A and Class B Common Stock | · | · | 201 | Erworben |
| 30. Juli 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 45 | Erworben |
| 30. Juli 2009 | PEG | Phantom Stock | Common Stock | · | 8. August 1988 | 45 | Erworben |
Zeige die neuesten 100 von 231 Transaktionen
Ausübungs-/Umwandlungspreis ist leer, wenn nicht zutreffend (z. B. RSUs).
Anfänglicher Besitz (Formular 3) 1 Beteiligung
Wertpapiere, die beim erstmaligen Eintritt als Insider gehalten wurden, gemäß SEC Formular 3.
| Date | Ticker | Wertpapier | Aktien | Besitz |
|---|---|---|---|---|
| 22. September 2006 | CVS | Common Stock | 1.000 | Direkt |